Announced
Completed
Financials
Tags
Switzerland
Cross Border
Majority
Biotechnology
Acquisition
Private
Friendly
Single Bidder
protein biochemistry
Completed
Synopsis
Nordic BioSite, a supplier of products for research and diagnostics, completed the acquisition of LubioScience, a company that offers a select range of R&D products for protein biochemistry, cell culture and general lab reagents of high quality. Financial terms were not disclosed. “Switzerland is a key research hub in Europe and hence we have been eager to be present there to help existing and new suppliers gain access to this fast-growing market. LubioScience has been #1 on our target list for a long time as we have been impressed with the success they have had in the Swiss market. I am sure there are many things we can learn from their success to replicate within the Group, just like we can transfer our commercial and operational best practices to LubioScience” Sune Schmolker, Nordic BioSite CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.